AstraZeneca's lengthy and turbulent development of CTLA4 inhibitor tremelimumab has at least led to a regulatory approval as part of a combination therapy for advanced liver cancer. Tremelimumab ...

AstraZeneca is a company with a turbulent history but, for now, a promising future. We take a look at the company's story, from its creation as a merger of two equals, to its recent major ...

Review the current valuation for AstraZeneca PLC ADR (AZN:XNAS) stock based on a yearly calendar providing PE ratios, cash flow, EBITDA and other company valuation information.

See the latest AstraZeneca PLC ADR stock price (AZN:XNAS), related news, valuation, dividends and more to help you make your investing decisions.

The Currencies Heat Map is a set of tables which display the relative strengths of major currency pairs in comparison with each other.

We've had lawless criminals, samurai's, and the Empire, and now it's a Super season as Chapter 6 continues on a revamped Fortnite C6S4 map.

Listen live to BBC Radio Ulster on BBC Sounds ...

AstraZeneca, a globally leading biopharmaceutical company, kicked off construction on a new small molecule drug manufacturing facility in Wuxi, East China's Jiangsu province, on May 8, marking a ...

Find annual and quearterly earnings data for AstraZeneca PLC American Depositary Shares (AZN) including earnings per share, earnings forecasts at Nasdaq.com.

We have Today's Contexto Answer for you so that you don't have to lose your streak if you're having a hard time with the puzzle!